• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Does Adding Psychotherapy Help Patients With Resistant Depression?

Does Adding Psychotherapy Help Patients With Resistant Depression?

February 1, 2010
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Section editor, Glen Spielmans, PhD

Patients who don’t respond well to medication for depression are often referred for psychotherapy. But there has been little evidence that this actually works.A recent trial attempted to assess whether this method could help patients. Researchers assigned a group of 808 patients, all of whom had been chronical- ly depressed for more than two years, to one of five antidepressants based on an algorithm (possibilities included sertraline, escitalopram, bupropion, venlafaxine, or mirtazapine).Those who did not respond to the medication by 12 weeks (491 patients total) had their med- ication regimens optimized according to a predefined algorithm. In this algorithm (referred to as “MEDS” in the paper) patients with no response to the first medication were switched to a different antidepressant, while those with a partial response received augmentation with either bupropion or venlafaxine.These patients were then randomly assigned to one of three conditions: MEDS alone, MEDS plus supportive therapy, or MEDS plus a type of cognitive behavioral thera- py. Outcomes were measured after 12 weeks on the Hamilton depression scale, and there was no significant difference in either remission rates (average of 15%) or partial response rates (22.5%).Thus, sur- prisingly, adding psychotherapy offered no notable advantages over medication by itself (Kocsis JH et al., Arch Gen Psychiatry 2009;66:1178–1188).

TCPR's Take: Before we conclude that adding psychotherapy does not help patients with treatment resistant depression, it is important to note that the “medication only” patients received more clinician contact than is typical. These patients had, on average, 5.2 visits with their psychiatrists over the course of the 12-week study, a visit frequency of nearly every two weeks.These frequent visits could have boosted response to medication. Also, the patients in this study were apparently skeptical of the benefits of psychotherapy—the authors reported that participants often “required considerable convincing” that psy- chotherapy was valuable. Finally, these results were specific to treatment-resist- ant depression; a prior meta-analysis found that adding psychotherapy at the start of depression treatment is associated with better outcomes than medication alone (Pampallona S et al., Arch Gen Psychiatry 2004;61:71–719).

General Psychiatry
KEYWORDS depressive_disorder psychotherapy
    www.thecarlatreport.com
    Issue Date: February 1, 2010
    SUBSCRIBE NOW
    Table Of Contents
    An Update on Natural Treatments
    When Natural Treatments are Debunked: Lessons for Practitioners
    Complementary Treatments in Psychiatry
    Combined Treatment Works Better Than Risperidone Alone for PDD
    Does Adding Psychotherapy Help Patients With Resistant Depression?
    Five Treatments for Smoking Cessation Compared
    DOWNLOAD NOW
    Featured Book
    • PB4e_Cover2.png

      Psychiatry Practice Boosters, Fourth Edition (2023)

      Teaches you the key points of 63 of the most clinically relevant studies in psychiatry.
      READ MORE
    Featured Video
    • therapist_canstockphoto9201097.jpg
      General Psychiatry

      Using SAMe In Clinical Practice with Garrett Rossi, MD

      Read More
    Featured Podcast
    • canstockphoto6759394.jpg
      General Psychiatry

      Throwback Thursday: Brief Therapy for ADHD

      You started a stimulant medication for a young woman with ADHD. When she returns her symptoms are 70% better, but what can we do about the rest? Today a conversation with...

      Listen now
    Recommended
    • Approaches to Autism Intervention

      January 31, 2022
      canstockphoto2240982_child-bubbles_thumb.jpg
    • Currently Available Cannabis Products

      September 1, 2022
    • Interpreting Assessment Discrepancies from Multiple Sources

      October 17, 2022
      ChildAssessment.png
    • Approaches to Autism Intervention

      January 31, 2022
      canstockphoto2240982_child-bubbles_thumb.jpg
    • Currently Available Cannabis Products

      September 1, 2022
    • Interpreting Assessment Discrepancies from Multiple Sources

      October 17, 2022
      ChildAssessment.png
    • Approaches to Autism Intervention

      January 31, 2022
      canstockphoto2240982_child-bubbles_thumb.jpg
    • Currently Available Cannabis Products

      September 1, 2022
    • Interpreting Assessment Discrepancies from Multiple Sources

      October 17, 2022
      ChildAssessment.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    info@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2023 Carlat Publishing, LLC and Affiliates, All Rights Reserved.